BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Nihon Kohden America, Inc. Facilitates Faster Access to Patient Information via the Mobile Monitoring of Patients With Introduction of iPhone and iPad Application


10/11/2012 10:18:24 AM

FOOTHILL RANCH, Calif.--(BUSINESS WIRE)--Nihon Kohden America, a market leader in patient monitoring innovation, now gives hospital staff faster access to patient information, especially if patients are experiencing adverse events, with the introduction of its first iPad and iPhone application. Nihon Kohden America designed the app to allow hospital staff to take its Defensive and Enterprise Monitoring™ strategy mobile anywhere a clinician requires immediate access to patients near real-time and retrospective data. The innovative mobile monitoring strategy is unique in that it lets medical personnel monitor and track multiple patients’ trends on vital statistics on a continuous basis. The app operates with both Nihon Kohden’s Enterprise Monitoring System and its award-winning Prefense — Early Detection and Notification System, which now permits hospitals to monitor opioid-drip patients for end tidal CO2 (EtCO2), oxygen saturation (SpO2), respiration rate, heart rate and noninvasive blood pressure.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES